|
Q4 2021
Filed on Feb 09, 2022
|
7,459
|
$38.92 - $42.05
$290K - $314K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
16,623
|
N/A
|
|
Principal Exchange Traded Fd
|
Q4 2021
Filed on Feb 09, 2022
|
56,897
|
N/A
|
|
Dicerna Pharmaceuticals Inc
|
Q4 2021
Filed on Feb 09, 2022
|
29,760
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
114,428
|
$12.24 - $21.25
$1.4M - $2.43M
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
1,007
|
$207.24 - $275.3
$209K - $277K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
5,001
|
$44.73 - $45.64
$224K - $228K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
17,409
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
40,448
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
24,820
|
$0.6 - $1.11
$14.9K - $27.6K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
10,222
|
$11.35 - $97.17
$116K - $993K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
30,110
|
$19.38 - $24.89
$584K - $749K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
18,730
|
$44.18 - $53.27
$827K - $998K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
7,476
|
$105.06 - $113.44
$785K - $848K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
4,311
|
$101.38 - $109.77
$437K - $473K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
25,210
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
9,736
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
14,400
|
N/A
|
|
American National Group Inc
|
Q4 2021
Filed on Feb 09, 2022
|
11,988
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
16,511
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
5,914
|
$55.78 - $65.48
$330K - $387K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
23,368
|
$3.74 - $6.7
$87.4K - $157K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
10,400
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
8,889
|
$13.6 - $24.89
$121K - $221K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
5,064
|
$27.59 - $66.39
$140K - $336K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
12,231
|
$1.16 - $2.74
$14.2K - $33.5K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
37,107
|
$9.93 - $11.61
$368K - $431K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
10,674
|
$2.04 - $3.59
$21.8K - $38.3K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
12,598
|
$3.13 - $3.73
$39.4K - $47K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
10,627
|
$5.14 - $6.84
$54.6K - $72.7K
|
|
Strongbridge Biopharma PLC
|
Q4 2021
Filed on Feb 09, 2022
|
93,064
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
12,239
|
$3.26 - $4.66
$39.9K - $57K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
10,511
|
$1.3 - $3.17
$13.7K - $33.3K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
47,152
|
$51.18 - $52.61
$2.41M - $2.48M
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
23,447
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
74,000
|
$2.47 - $5.55
$183K - $411K
|
|
Xeris Pharmaceuticals Inc
|
Q4 2021
Filed on Feb 09, 2022
|
11,801
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
3,725
|
$21.49 - $74.4
$80.1K - $277K
|
|
Gs Acquisition Hldgs Corp Ii
|
Q4 2021
Filed on Feb 09, 2022
|
877,768
|
N/A
|
|
Gs Acquisition Hldgs Corp Ii
|
Q4 2021
Filed on Feb 09, 2022
|
732,954
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2021
Filed on Feb 09, 2022
|
12,564
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
7,998
|
$28.79 - $32.36
$230K - $259K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
10,023
|
$37.74 - $40.41
$378K - $405K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
3,100
|
$39.64 - $72.06
$123K - $223K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
65,246
|
$9.07 - $13.25
$592K - $865K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
5,771
|
$37.3 - $46.5
$215K - $268K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
3,667
|
$140.47 - $150.69
$515K - $553K
|
|
Adamas Pharmaceuticals Inc
|
Q4 2021
Filed on Feb 09, 2022
|
63,167
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
10,475
|
$3.5 - $9.63
$36.7K - $101K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
422,284
|
$4.68 - $5.99
$1.98M - $2.53M
|
|